Loading…
Kwality Pharmaceuticals (KPL)₹3,856+4.62%Pharmaceuticals
Kwality Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 49.3 against a peer median of 45.6, and ROCE of 24.0% against a peer median of 14.5%, and latest-quarter sales growth of 46.0% against a peer median of 20.0%. By market cap it is #9 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Supriya Lifescience | 5,082 | 24.3 | 25.1 | 19.1 | 0.00 | 0.2 | 826 | 209 | 50.7 | 48.1 | vs KPL |
| SMS Pharmaceuticals | 4,809 | 46.8 | 13.0 | 14.2 | 0.46 | 0.1 | 886 | 102 | 5.6 | 4.9 | vs KPL |
| Gufic Biosciences | 4,760 | 64.8 | 12.0 | 10.2 | 0.61 | 0.0 | 948 | 64 | 16.6 | 69.1 | vs KPL |
| Aarti Drugs | 4,563 | 24.0 | 12.1 | 13.4 | 0.37 | 0.4 | 2,564 | 194 | 18.9 | −7.5 | vs KPL |
| Zota Health Care | 4,410 | — | −8.0 | −15.1 | 0.39 | 0.1 | 539 | −74 | 54.2 | — | vs KPL |
| Evonile Pharma | 4,343 | 44.5 | 16.0 | 11.7 | 0.00 | 0.0 | 353 | 93 | 18.1 | 14.3 | vs KPL |
| RPG Life Sciences | 4,283 | 39.1 | 26.0 | 19.3 | 0.03 | 0.9 | 708 | 115 | 16.4 | −24.3 | vs KPL |
| Gujarat Themis Biosyn | 4,138 | 88.5 | — | — | — | 0.2 | 165 | 47 | 22.3 | 22.5 | vs KPL |
| Kwality Pharmaceuticals | 4,011 | 49.3 | 24.0 | 22.9 | 0.39 | 0.0 | 503 | 67 | 46.0 | 116.4 | — |
| Shukra Pharmaceuticals | 3,618 | 110.9 | 36.9 | 28.9 | 0.06 | 0.0 | 57 | 22 | 379.2 | 1,191.1 | vs KPL |
| Unichem Laboratories | 3,584 | 11.7 | 4.0 | 3.2 | 0.18 | 0.0 | 2,200 | 253 | 20.0 | — | vs KPL |
| Peer median | 4,343 | 45.6 | 14.5 | 13.8 | 0.28 | 0.1 | 708 | 93 | 20.0 | 22.5 |
Listed companies closest to Kwality Pharmaceuticals in Pharmaceuticals include Supriya Lifescience, SMS Pharmaceuticals, Gufic Biosciences, Aarti Drugs, Zota Health Care, Evonile Pharma, RPG Life Sciences, Gujarat Themis Biosyn.
Supriya Lifescience, with a market cap of ₹5,082 Cr.
Kwality Pharmaceuticals trades at a P/E of 49.3; the median of its peer set is 45.6. A P/E above or below the median is a description, not a judgement on value.
Kwality Pharmaceuticals' return on capital employed is 24.0%, above the peer median of 14.5%.